search
Back to results

M. Hailey-Hailey: hSPCA1 Expression and Skin Structure Upon Laser Therapy

Primary Purpose

Hailey Hailey Disease

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Skin biopsy
Sponsored by
Maastricht University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Hailey Hailey Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinically diagnosed M. Hailey-Hailey as confirmed by histopathology and/or genetic analysis.
  • Indication for ablative laser therapy
  • >18 years old
  • Informed consent

Exclusion Criteria:

  • <18 years old
  • Treatment with tetracyclines, topical hormones or oral retinoids within the last 30 days preceding participation
  • Lack of informed consent

Sites / Locations

  • Maastricht University Medical CenterRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Hailey Hailey

Arm Description

Patients with Hailey Hailey, diagnosis confirmed by histopathology or genetics, with therapy resistant skin lesions suitable for ablative lasertherapy. Skin biopsy specimens will be taken before and after lasertherapy at three time points. Before treatment: Affected skin 4 mm punch for immunofluorescence and RNA extraction 2 mm for electron microscopy Healthy skin within same anatomical region 4 mm punch for immunofluorescence and RNA extraction Immediately after treatment of the treated area: 2 mm punch for histopathology Six weeks after treatment: Treated skin 4 mm punch for immunofluorescence and RNA extraction 2 mm for electron microscopy

Outcomes

Primary Outcome Measures

hSPCA1 expression
Expression of the hSPCA1 calcium pump in keratinocytes before ablative treatment
hSPCA1 expression
Expression of the hSPCA1 calcium pump in keratinocytes after ablative treatment

Secondary Outcome Measures

Ultrastructure of the skin before and after ablative treatment by electron microscopy.
Cell-to-cell adhesion and desmosome ultrastructure before and after ablative treatment by electron microscopy.
Expression and localization of desmosomal proteins before and after ablative therapy by immunofluorescence.
Expression and localization of desmosomal proteins before and after ablative therapy by immunofluorescence.

Full Information

First Posted
February 19, 2019
Last Updated
February 20, 2019
Sponsor
Maastricht University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03849989
Brief Title
M. Hailey-Hailey: hSPCA1 Expression and Skin Structure Upon Laser Therapy
Official Title
Expression of hSPCA1 and Ultrastructural Analysis of the Skin Before and After Laser Therapy in Hailey-Hailey Disease
Study Type
Interventional

2. Study Status

Record Verification Date
February 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 21, 2018 (Actual)
Primary Completion Date
June 19, 2020 (Anticipated)
Study Completion Date
June 19, 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Maastricht University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Hailey-Hailey disease is a genetic acantholytic dermatosis characterized by continuous erosion of the skin that results in a burning, painful sensation and restricts the patient in daily life. This disorder results from a genetic defect in a calcium pump, i.e. the hSPCA1 pump. Calcium pumps are crucial for the processing of cell-cell adhesion proteins such as E-cadherin, part of desmosomes, the major glue between keratinocytes in skin epidermis. Today therapy is mainly focussed on symptom relief and prevention of secondary infection. Ablative laser therapy is known to result in a speedy healing of the affected skin site within 2 weeks following laser therapy. The fact that the treated skin site remains clear from this acantholytic disorder in the months/years following ablation, regardless the existence of a germline mutation, suggests that an epigenetic modification occurs in the process of wound healing. Objective: to (1) study the expression of hSPCA1 in keratinocytes before and after laser therapy and (2) verify the loss of acantholysis by immunohistochemistry and electron microscopy of cell-cell adhesions before and after laser therapy

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hailey Hailey Disease

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Hailey Hailey
Arm Type
Experimental
Arm Description
Patients with Hailey Hailey, diagnosis confirmed by histopathology or genetics, with therapy resistant skin lesions suitable for ablative lasertherapy. Skin biopsy specimens will be taken before and after lasertherapy at three time points. Before treatment: Affected skin 4 mm punch for immunofluorescence and RNA extraction 2 mm for electron microscopy Healthy skin within same anatomical region 4 mm punch for immunofluorescence and RNA extraction Immediately after treatment of the treated area: 2 mm punch for histopathology Six weeks after treatment: Treated skin 4 mm punch for immunofluorescence and RNA extraction 2 mm for electron microscopy
Intervention Type
Procedure
Intervention Name(s)
Skin biopsy
Intervention Description
Skin biopsy: Tissue samples will be taken by punch biopsy according to the daily routine of the Department of Dermatology of the Maastricht UMC+. Steps: Skin desinfection with chlorhexidine digluconate 1% solution Local anaesthesia with lidocaine hydrochloride 1% Biopsy specimens are taken with sterile punch device (disposable biopsy punch delivered by kai medical) Biopsy specimens are retrieved with sterile pincer and cut with sterile blade Wound is stitched with a single transcutaneous stich using absorbable suture (vicryl 4.0). Wound will be treated with R/ fusidic acid ointment 3 to 5 times per day for two weeks In the first week after laser therapy the wound will be covered by R/ Urgotull non-adhesive gauze, R/ Cutisoft cotton non-sterile gauze and R/ Klinipress exsupad absorbing bandage.
Primary Outcome Measure Information:
Title
hSPCA1 expression
Description
Expression of the hSPCA1 calcium pump in keratinocytes before ablative treatment
Time Frame
Assessed at time point 0 weeks
Title
hSPCA1 expression
Description
Expression of the hSPCA1 calcium pump in keratinocytes after ablative treatment
Time Frame
Assessed 6 weeks after ablative treatment
Secondary Outcome Measure Information:
Title
Ultrastructure of the skin before and after ablative treatment by electron microscopy.
Description
Cell-to-cell adhesion and desmosome ultrastructure before and after ablative treatment by electron microscopy.
Time Frame
At 0 weeks and 6 weeks after ablative therapy
Title
Expression and localization of desmosomal proteins before and after ablative therapy by immunofluorescence.
Description
Expression and localization of desmosomal proteins before and after ablative therapy by immunofluorescence.
Time Frame
At 0 weeks and 6 weeks after ablative therapy

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinically diagnosed M. Hailey-Hailey as confirmed by histopathology and/or genetic analysis. Indication for ablative laser therapy >18 years old Informed consent Exclusion Criteria: <18 years old Treatment with tetracyclines, topical hormones or oral retinoids within the last 30 days preceding participation Lack of informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Valerie Verstraeten, MD PhD
Phone
0031/433877295
Email
valerie.verstraeten@mumc.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Valerie Verstraeten, MD PhD
Organizational Affiliation
Maastricht University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Maastricht University Medical Center
City
Maastricht
State/Province
Limburg
ZIP/Postal Code
6202 AZ
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Valerie Verstraeten, MD PhD
Phone
0031/433877295
Email
valerie.verstraeten@mumc.nl

12. IPD Sharing Statement

Plan to Share IPD
No
Links:
URL
https://www.ncbi.nlm.nih.gov/pubmed/22639968
Description
Hailey-Hailey disease and tight junctions: Claudins 1 and 4 are regulated by ATP2C1 gene encoding Ca(2+) /Mn(2+) ATPase SPCA1 in cultured keratinocytes.
URL
https://www.ncbi.nlm.nih.gov/pubmed/23582735
Description
Carbon dioxide laser treatment in Hailey-Hailey disease: a series of 8 patients.
URL
https://www.ncbi.nlm.nih.gov/pubmed/?term=The+coexistence+of+Darier's+disease+and+Hailey-Hailey+disease+symptoms.
Description
The coexistence of Darier's disease and Hailey-Hailey disease symptoms.
URL
https://www.ncbi.nlm.nih.gov/pubmed/?term=Efficacy+of+erbium%3AYAG+laser+ablation+in+Darier+disease+and+Hailey-Hailey+disease
Description
Efficacy of erbium:YAG laser ablation in Darier disease and Hailey-Hailey disease.
URL
https://www.ncbi.nlm.nih.gov/pubmed/?term=Carbon+dioxide+laser+treatment+for+Hailey-Hailey+disease%3A+a+retrospective+chart+review+with+patient-reported+outcomes.
Description
Carbon dioxide laser treatment for Hailey-Hailey disease: a retrospective chart review with patient-reported outcomes.
URL
https://www.ncbi.nlm.nih.gov/pubmed/?term=Laser+therapy+for+the+treatment+of+Hailey-Hailey+disease%3A+a+systematic+review+with+focus+on+carbon+dioxide+laser+resurfacing.
Description
Laser therapy for the treatment of Hailey-Hailey disease: a systematic review with focus on carbon dioxide laser resurfacing.

Learn more about this trial

M. Hailey-Hailey: hSPCA1 Expression and Skin Structure Upon Laser Therapy

We'll reach out to this number within 24 hrs